Find a Therapeutic By Name

Search By Attributes

Therapy Type

Combination
DNA/RNA-based
Immunotherapy (active)
Immunotherapy (passive)
Other
Procedural Intervention
Small Molecule
Supplement, Dietary

Condition

Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Cerebral Amyloid Angiopathy
Frontotemporal Dementia
Mild Cognitive Impairment
Parkinson's Disease

Keyword

1 Therapeutic

Search Results

Name	Synonyms	FDA Status	Company	Target Type	Therapy Type	Approved For
Amilomotide	CAD106	Alzheimer's Disease (Inactive)	Novartis Pharmaceuticals Corporation	Amyloid-Related	Immunotherapy (active)	None